Specialized Accelerator for Pharmaceutical Exports: A Local Business Model Proposal
Keywords:
Public sector fraud, fraud prevention, forensic accounting.Abstract
The model for fraud prevention in the public sector using forensic accounting is designed based on the identification and analysis of weaknesses in existing financial and administrative processes. Enhancing transparency and accountability in financial and administrative reports can help reduce the risk of fraud. Additionally, the use of modern technologies such as big data and advanced analytics can assist in detecting suspicious patterns and abnormal behaviors. Ultimately, this model must be designed to align with the specific cultural, economic, and political characteristics of each country or public institution to effectively prevent fraud and enhance public trust. Therefore, this study was conducted with the aim of proposing a model for fraud prevention in the public sector through forensic accounting. The data required for Interpretive Structural Modeling (ISM) was gathered through interviews with 15 experts, specifically senior managers in the public sector who held at least a master's degree in accounting or auditing and had experience in forensic accounting (judiciary-appointed experts). In this research, a model was designed using ISM. The results of the ISM structural analysis, through the exploratory model, indicated that the dimensions of integrating forensic accounting and big data technology include digital evidence collection, collaboration with cybersecurity experts, a robust line of defense against fraud, and the development of appropriate structures and processes. Forensic accounting encompasses fraud detection and analysis, training and expertise, and cooperation with legal institutions. Big data technology includes dimensions such as identifying anomalous patterns, analyzing multi-source data, and enhancing information security.
References
S. Singh, "Assessing India's Export Potential to European Union Markets: Opportunities and Challenges," Jier, vol. 5, no. 1, 2025, doi: 10.52783/jier.v5i1.2360.
M. Ansari, A. Takian, and V. Yazdi‐Feyzabadi, "The Challenges of Iran's Pharmaceutical Export: A Qualitative Content Analysis," Evidence Based Health Policy Management and Economics, 2022, doi: 10.18502/jebhpme.v6i3.10858.
Z. A. Aladysheva, В. В. Береговых, A. P. Meshkovskiy, and N. V. Pyatigorskaya, "Refinement of Drug Regulation and Russian Pharmaceutical Export," Federalism, vol. 28, no. 4, pp. 157-183, 2023, doi: 10.21686/2073-1051-2023-4-157-183.
Z. A. Aladysheva, В. В. Береговых, A. P. Meshkovskiy, and N. V. Pyatigorskaya, "Drug Regulation in Top Exporters of Pharmaceutical Products," Federalism, vol. 28, no. 3, pp. 108-136, 2023, doi: 10.21686/2073-1051-2023-3-108-136.
А. А. Халимова, Ж. С. Сафронова, А. В. Коваленко, M. Grishina, and А. А. Маклакова, "Export of Russian Pharmaceutical Products: Dynamics, Structure and Main Directions," vol. 7, no. 3, pp. 278-289, 2024, doi: 10.58224/2658-5286-2024-7-3-278-289.
P. Chakraborty, "Indian Pharmaceuticals Industry in Global Scenario: An Appraisal," Journal of Health Management, vol. 22, no. 3, pp. 424-429, 2020, doi: 10.1177/0972063420937939.
A. Kolte, G. Festa, M. Rossi, A. Thrassou, D. Vrontis, and M. Christofi, "Ambidexterity's Influence on Export Strategy Development—The Case of the Indian Pharmaceutical Industry," Thunderbird International Business Review, vol. 64, no. 5, pp. 465-476, 2022, doi: 10.1002/tie.22278.
A. Jassbi, M. Jafari, M. M. Mazdeh, and M. Maleki, "Structure Model of Foresightful Export Oriented Strategies for Iran Pharmaceutical Industry: Using a Fuzzy DEMATEL Method," Ircmj, 2021, doi: 10.32592/ircmj.2021.23.11.1113.
M. Mohammadzadeh, N. Bakhtiari, R. Safarey, and T. Ghari, "Pharmaceutical Industry in Export Marketing: A Closer Look at Competitiveness," International Journal of Pharmaceutical and Healthcare Marketing, vol. 13, no. 3, pp. 331-345, 2019, doi: 10.1108/ijphm-02-2018-0011.
S. Z. Joneghani and H. Z. Joneghani, "Identification and Ranking the Effective Factors for Export Promotion in Pharmaceutical Companies," Management Science Letters, pp. 357-364, 2019, doi: 10.5267/j.msl.2018.12.013.
N. A. Volgina, "Business Models of Big Pharma in Russia: A Pharmaceutical Value Chain Perspective," Rudn Journal of Economics, vol. 30, no. 1, pp. 57-69, 2022, doi: 10.22363/2313-2329-2022-30-1-57-69.
J. Vieira, R. Frade, R. Ascenso, F. Martinho, and D. Martinho, "Determinants of Internationalization as Levers for Sustainability: A Study of the Portuguese Pharmaceutical Sector," 2021, doi: 10.20944/preprints202107.0088.v2.
S. Voitovych, V. Serzhanov, О. Ковальчук, N. Bukalo, and V. Zagorujko, "Consideration the Peculiarities of Inter-Market Interactions of Subjects in Marketing Strategic Management," Actual Problems of Economics, vol. 1, no. 254, pp. 49-58, 2022, doi: 10.32752/1993-6788-2022-1-254-49-58.
M. Schur, "Georgia Exports and Value Chain Study," 2024, doi: 10.22617/tcs240433-2.
O. Klochko and A. V. Chugunova, "Impact of Cross-Border Mergers and Acquisitions on the Development of Chinese Pharmaceutical Exports and Imports," Outlines of Global Transformations Politics Economics Law, vol. 12, no. 6, pp. 170-187, 2019, doi: 10.23932/2542-0240-2019-12-6-8.
А. R. Shaikhislamova and N. A. Gasratova, "Mathematical Modeling and Analysis of Export Trends for Certain Pharmaceutical Groups," Farmakoekonomika Modern Pharmacoeconomics and Pharmacoepidemiology, vol. 17, no. 2, pp. 152-162, 2024, doi: 10.17749/2070-4909/farmakoekonomika.2024.246.
T. Shabelnyk, "The Method of Hierarchy Analysis as a Mechanism for Choosing a Development Strategy for a Pharmaceutical Enterprise," Business Inform, vol. 9, no. 548, pp. 117-122, 2023, doi: 10.32983/2222-4459-2023-9-117-122.
N. K. C. Kerdpitak, "Marketing Capabilities Model for Pharmaceutical Business in Thailand," Turkish Journal of Computer and Mathematics Education (Turcomat), vol. 12, no. 6, pp. 1421-1430, 2021, doi: 10.17762/turcomat.v12i6.2681.
A. A. Shraah, A. Abu-Rumman, L. Alqhaiwi, and H. AlSha’ar, "The Impact of Sourcing Strategies and Logistics Capabilities on Organizational Performance During the COVID-19 Pandemic: Evidence From Jordanian Pharmaceutical Industries," Uncertain Supply Chain Management, vol. 10, no. 3, pp. 1077-1090, 2022, doi: 10.5267/j.uscm.2022.2.004.
L. Chu et al., "Mining and Engineering Exporters for Titer Improvement of Macrolide Biopesticides in Streptomyces," Microbial Biotechnology, vol. 15, no. 4, pp. 1120-1132, 2021, doi: 10.1111/1751-7915.13883.
H. S. M. Elguwiri, "Influence of Product Quality on International Competitiveness of Domestic Pharmaceutical Companies," Problems and Prospects of Economic and Management, no. 4(28), pp. 136-142, 2021, doi: 10.25140/2411-5215-2021-4(28)-136-142.
M. A. B. Lawate, D. M. Shinde, and S. K. Bais, "Pharmaceutical Sales and Marketing," International Journal of Advanced Research in Science Communication and Technology, pp. 606-615, 2023, doi: 10.48175/ijarsct-7920.
K. D. Pandey, A. Narula, R. Singhal, and N. Kumar, "An Empirical Assessment of the Impact and Role of the Indenting Agents in the Supply Chain of Pharmaceutical Raw Material From China," Journal of Statistics and Management Systems, vol. 26, no. 7, pp. 1673-1686, 2023, doi: 10.47974/jsms-1133.
S. W. Roberts et al., "Control Strategy Expectations in Early Clinical Phase Synthetic Oncology Programs: Two Global Regulatory Case Studies," Organic Process Research & Development, vol. 24, no. 1, pp. 96-100, 2020, doi: 10.1021/acs.oprd.9b00479.
V. V. Zhoglicheva, "Import Farmatsevticheskoi Produktsii v Rossiiskuiu Federatsiiu," pp. 92-112, 2021, doi: 10.31483/r-99289.
Ф. А. Кураков, "Strategies for Retention Global Leadership of Small High-Tech Companies in Narrowly Focused Markets," The Economics of Science, vol. 4, no. 2, pp. 115-126, 2018, doi: 10.22394/2410-132x-2017-4-2-115-126.
J. A. Qureshi, R. M. Ellahi, and F. M. Khuwaja, "Sheikhs on a Roller Coaster: The Case of Matcon Pharmaceutical," Emerald Emerging Markets Case Studies, vol. 15, no. 2, pp. 1-20, 2025, doi: 10.1108/eemcs-04-2024-0188.
Downloads
Published
Submitted
Revised
Accepted
Issue
Section
License
Copyright (c) 2025 Mahmoud Zamani

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.